Picture Berlin Partner HealthCapital Bionnale 2018 Germany June 600x60px
Document › Details

bioMérieux S.A.. (4/15/14). "Press Release: Alexandre Mérieux Assumes Role of bioMérieux CEO". Marcy l’Étoile.

Organisations Organisation bioMérieux (Group)
  Group Mérieux (Group)
  Organisation 2 Image Sept (FR)
Products Product in vitro diagnostics (IVD)
  Product 2 diagnostics (medical/biological)
Persons Person Mérieux, Alexandre (Mérieux 201712– CEO at bioMérieux before Deputy CEO before VP Industrial Microbiology)
  Person 2 Bélingard, Jean-Luc (Mérieux 201101– Président Directeur Général before Ipsen CEO + Pierre Fabre + Roche Diagnostics)

Alexandre Mérieux will take on the role of Chief Executive Officer of bioMérieux and head its Management Committee. To step up the rollout of its strategic plan, a new organization is being deployed.

The Management Committee, led by Alexandre Mérieux, is in charge of implementing the strategy decided by bioMérieux's Board of Directors, which remains chaired by Jean-Luc Belingard. The Committee's main missions are to define the priority action and development areas, oversee strategic projects and allocate the necessary resources to the different departments within the Group.

Evolution of the operational organization

To continue bioMérieux's international development and always better serve customers, three regional organizations with expanded responsibilities have been created: a Europe-Middle East-Africa region, an Americas region and an Asia-Pacific region. In parallel, two business units for bioMérieux's customer segments, a Clinical Unit and an Industry Unit, have been established.

The Business Development, Molecular Biology and Quality departments will report to Jean-Luc Belingard. All other departments, including Investor Relations, will report to Alexandre Mérieux. Jean-Luc Belingard, Chairman, stated: "I am very pleased to see Alexandre Mérieux take on the role of CEO. In the past three years, we have made major acquisitions and business agreements that hold exciting prospects for our Company. We will work with Alexandre to bring them to fruition with a shared humanist and long-term vision".

Alexandre Mérieux, Chief Executive Officer, adds: "My new role is an extension of our family's commitment to bioMérieux's development. I will be able to count on Jean-Luc Belingard's support, an outstanding Board and teams I know well and who have, time and time again, demonstrated their dedication to serving biologists and patients".


Pioneering Diagnostics

A world leader in the field of in vitro diagnostics for 50 years, bioMérieux is present in more than 150 countries through 41 subsidiaries and a large network of distributors. In 2013, revenues reached €1,588 million with 87% of sales outside of France.

bioMérieux provides diagnostic solutions (reagents, instruments, software) which determine the source of disease and contamination to improve patient health and ensure consumer safety. Its products are used for diagnosing infectious diseases and providing high medical value results for cancer screening and monitoring and cardiovascular emergencies. They are also used for detecting microorganisms in agri-food, pharmaceutical and cosmetic products.

bioMérieux is listed on the NYSE Euronext Paris market (Symbol: BIM - ISIN: FR0010096479). Corporate website: Investor website:


Investor Relations

Isabelle Tongio
Tel: + 33 4 78 87 22 37

Media Relations

Aurore Sergeant
Tel: + 33 4 78 87 54 75

Image Sept
Laurence Heilbronn
Tel: + 33 1 53 70 74 64
Claire Doligez
Tel: + 33 1 53 70 74 48

Record changed: 2016-01-10


Picture EBD Group Biotech Showcase 2019 San Francisco BTS January 600x60px

More documents for Mérieux (Group)

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to and simply fill the subject line with the word »MSC Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at and


Picture EBD Group Bio-Europe 2018 Copenhagen Denmark November 600x60px

» top